Skip to main content
Fig. 4 | BMC Anesthesiology

Fig. 4

From: Remifentanil requirement for i-gel insertion is reduced in male patients with Parkinson’s disease undergoing deep brain stimulator implantation: an up-and-down sequential allocation trial

Fig. 4

Changes in HR, MAP and BIS during i-gel insertion. Data are presented as mean ± SD. PD, Parkinson’s disease; NPD, non- Parkinson’s disease. T0, baseline; T1, 1 min. after propofol infusion; T2, 3 min. after propofol infusion; T3, 5 min. after propofol infusion and starting time of remifentanil infusion; T4, 1 min. after remifentanil infusion; T5, 3 min. after remifentanil infusion; T6, 5 min. after remifentanil infusion; T7, 1 min. after i-gel insertion

Back to article page

BMC Anesthesiology

ISSN: 1471-2253

Contact us